At The Hormone Zone, we don’t guess—we measure, refine, and optimize.
Prostate health is one of the most misunderstood and poorly screened areas in modern medicine. For decades, men have been told to rely on a single lab value—the PSA. But here’s the truth:
PSA alone is not enough.
It’s nonspecific. It’s inconsistent. And far too often, it leads to unnecessary biopsies, anxiety, and overtreatment.
That’s why we’ve integrated EpiSwitch® Prostate Screening (PSE) into our advanced diagnostic approach—because our patients deserve precision, not probability.
What Is EpiSwitch®?
EpiSwitch® is a next-generation blood test that evaluates epigenetic signals—specifically 3D genomic biomarkers associated with prostate cancer.
Unlike PSA, which measures a protein, EpiSwitch analyzes how your DNA is actually functioning in real time.
- It combines five epigenetic biomarkers with PSA data to improve diagnostic accuracy
- It delivers a clear “low likelihood” or “high likelihood” result for prostate cancer
- Results are available in approximately 5 days from a simple blood draw
This is not just another lab—it’s a decision-making tool.
Why Traditional PSA Screening Falls Short
PSA testing has been the standard—but it comes with significant limitations:
- Roughly only 25% of men with elevated PSA actually have cancer
- High rates of false positives
- Leads to unnecessary biopsies, which carry risks:
- Infection
- Bleeding
- Erectile dysfunction
- Psychological stress
In fact, PSA alone has been estimated to be only ~55% accurate in detecting prostate cancer .
That’s not precision medicine.
The EpiSwitch Advantage: Precision Screening
EpiSwitch changes the game.
1. 94% Accuracy
EpiSwitch demonstrates ~94% diagnostic accuracy, significantly outperforming PSA alone
2. Reduces Unnecessary Biopsies
Clinical data shows it can reduce unnecessary biopsies by up to 79%
3. True Risk Stratification
Instead of vague interpretation, patients receive:
Low likelihood → Monitor and avoid invasive procedures
High likelihood → Move decisively toward imaging and biopsy
This is clarity in action.
How We Use EpiSwitch at The Hormone Zone
Our approach is never one-dimensional. We integrate EpiSwitch into a comprehensive prostate optimization strategy:
Step 1: Baseline Assessment
- PSA (total and free)
- Hormonal profile (testosterone, estradiol, DHT)
- Inflammatory and metabolic markers
Step 2: EpiSwitch Testing
Used in:
- Elevated or borderline PSA
- Family history of prostate cancer
- High-performance patients seeking proactive screening
- Patients wanting to avoid unnecessary biopsy
Step 3: Decision Pathway
Low Likelihood Result
- Active surveillance
- Optimize hormones, inflammation, and metabolic health
- Repeat monitoring
High Likelihood Result
- Advanced imaging (MRI, Doppler)
- Targeted urology referral
- Precision-guided biopsy if indicated
Who Should Consider EpiSwitch?
This test is ideal for:
- Men aged 45+ who want proactive screening
- Patients with elevated or rising PSA
- Men with a family history of prostate cancer
- High-level executives and high performers who demand certainty, not guesswork
The Hormone Zone Philosophy
We don’t practice reactive medicine.
We practice predictive, preventive, precision medicine.
EpiSwitch aligns perfectly with our philosophy:
- Less unnecessary intervention
- More intelligent decision-making
- Better outcomes with fewer risks
Because when it comes to prostate health, the goal isn’t just to detect disease—
It’s to guide the right decision at the right time.
Final Word
The future of prostate screening is not about more testing.
It’s about better testing.
EpiSwitch allows us to:
- Reduce fear
- Avoid unnecessary procedures
- Act decisively when it matters
And that’s exactly how medicine should be practiced.
If you’ve been told to “watch your PSA”…
If you’ve been advised to consider a biopsy…
Or if you simply want the most advanced screening available—
Schedule your consultation at The Hormone Zone in Scottsdale or Prescott.
Let’s replace uncertainty with precision.
